DANA HUMPHREY: Open Payments
NPI 1538505458 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,308 in 99 payments from 24 companies in 2025. Trend: 2023 $166 · 2024 $174 · 2025 $2,308
Food & beverage: $2,221Education: $87
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $465 |
| Teva Pharmaceuticals USA, Inc. | 11 | $263 |
| UCB, Inc. | 8 | $223 |
| JAZZ PHARMACEUTICALS INC. | 5 | $190 |
| AERIN MEDICAL INC. | 1 | $187 |
| Lundbeck LLC | 8 | $171 |
| CATALYST PHARMACEUTICALS, INC. | 4 | $108 |
| LivaNova USA, Inc. | 1 | $99 |
| Eisai Inc. | 3 | $95 |
| Lilly USA, LLC | 3 | $63 |
Products named: QULIPTA, Briviact, EPIDIOLEX, VIVAER STYLUS, AUSTEDO XR, VYEPTI, UBRELVY, FYCOMPA.
Industry payments across IN — which companies pay providers there.
